AOBiome

AOBiome Therapeutics, Inc. AOBiome has a pipeline of multiple, clinical-stage therapeutic candidates

life sciences company focused on transforming human health by developing microbiome-based therapies for local, nasal and systemic inflammatory conditions.

07/07/2026

https://thedermdigest.com/aob-pharma-taps-biorasi-to-execute-phase-2b-acne-trial-company-maintains-phase-3-ad-trial-timeline/

AOB Pharma, Inc. is teaming up with Biorasi, a Clinical Research Organization, to start executing a Phase 2b clinical trial in acne.

12/03/2025

AOB Pharma receives European Medicines Agency (EMA) positive decision on the pediatric investigation plan (PIP), supporting future development of B244 for the treatment of mild to moderate atopic dermatitis in children, adolescents, and adults in the European Union (EU)

CAMBRIDGE, Mass., Dec. 2, 2025 /PRNewswire/ -- AOB Pharma, Inc. ("AOBiome"), a leading clinical-stage biotechnology company focusing on inflammatory skin conditions with their lead asset B244 for the treatment of mild to moderate atopic dermatitis (AD) and pruritus, received a positive decision on t...

Address

Cambridge, MA
02142

Website

https://aobiome.com/, https://aobiomecosmetics.com/

Alerts

Be the first to know and let us send you an email when AOBiome posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to AOBiome:

Want your business to be the top-listed Health & Beauty Business in Cambridge?